1. [Cooperation between Clinics and Hospitals Using a Critical Path for G-CSF Prophylaxis in Cancer Chemotherapy].
- Author
-
Takahashi T, Takahashi F, Okada Y, Ito S, Ugata N, Shimasaki Y, Mochida H, Matsuda S, Okada T, Kumanomidou S, Jo Y, Adachi K, Ikejiri F, Onishi C, Kawakami K, Moriyama I, Inoue M, Miyake T, Suzuki R, and Suzumiya J more...
- Subjects
- Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Humans, Middle Aged, Retrospective Studies, Young Adult, Critical Pathways, Granulocyte Colony-Stimulating Factor therapeutic use, Neutropenia prevention & control
- Abstract
Background: Prophylactic granulocyte-colony stimulating factor(G-CSF)is necessary for some cancer patients receiving anti-cancer drugs. However, it is difficult for cancer patients in rural areas to receive G-CSF as outpatients because of inconvenient official transport, lack of public support, and low activity levels due to age. To resolve this problem, we began conducting a critical path(G-path)with regional medical institutions from 2011., Methods: We retrospectively surveyed the clinical records of cancer patients receiving prophylactic G-CSF using G-path at our hospital., Results: Eighty-two patients who were administered a total of 254 cycles of chemotherapy were examined between January 2011 and December 2016. Diseases included malignant lymphoma(n=64), pancreatic cancer(n=7), soft tissue sarcoma(n=5), and others(n=6). The median age of the patients was 70(range: 24-94)years. Fifty-three patients visited medical offices, and 31 patients visited regional hospitals. In 245 of 254(96%)cycles, planned G-CSF administration was performed. In 37 of 254(15%)cycles, infectious episodes developed, but patients needed hospitalization for only 5 cycles(2%)., Conclusion: Cooperation between clinics and hospitals using G-path reduced ambulatory burden and prevented severe infection. Cooperation in supportive care may allow for equal accessibility to cancer treatment. more...
- Published
- 2019